BCMA/TNFRSF17 Fc Chimera Protein 193-BC-050 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemBCMA/TNFRSF17 Fc Chimera Protein
CompanyR&D Systems, a Bio-Techne Brand
Price $454.00Supplier Page View Company Product Page
Catalog Number193-BC-050
SpeciesHuman
FormatLyophilized from a 0.2 µm filtered solution in PBS
Molecule NameBCMA/TNFRSF17
Size50 ug
Purity>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining
Molecular WeightObserved: 35-45 kDa, reducing conditions
Theoretical: 32 kDa (monomer)
ApplicationsBioactivity
Conjugate/TagUnconjugated
Source/Expression SystemNS0-derived Recombinant Human BCMA/TNFRSF17 Fc Chimera Protein, CF
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution
NCBI Full Gene NameTNF receptor superfamily member 17
NCBI Gene AliasesBCM, BCMA, CD269, TNFRSF13A

Available conjugates: Sizes Available: 50 ug

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(1) A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen ReceptorCancer immunology researchFebruary 3, 2026Burchett R, Morris CG, Ishak M, Serniuck NJ, Cummings DT, Baker CL, Marius R, Kazdhan N, Silvestri CM, Bell J, et al.

(2) Generation and validation of structurally defined antibody-siRNA conjugatesNucleic acids researchJune 4, 2020Nanna AR, Kel'in AV, Theile C, Pierson JM, Voo ZX, Garg A, Nair JK, Maier MA, Fitzgerald K, Rader C.

(4) Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myelomaOncotargetMay 25, 2018Bu DX, Singh R, Choi EE, Ruella M, Nunez-Cruz S, Mansfield KG, Bennett P, Barton N, Wu Q, Zhang J, et al.

(5) γ-Secretase directly sheds the survival receptor BCMA from plasma cellsNature communicationsJune 11, 2015Laurent SA, Hoffmann FS, Kuhn PH, Cheng Q, Chu Y, Schmidt-Supprian M, Hauck SM, Schuh E, Krumbholz M, Rübsamen H, et al.

(6) Enhanced immunogenicity of HIV-1 envelope gp140 proteins fused to APRILPloS oneJanuary 1, 2014Isik G, Sliepen K, van Montfort T, Sanders RW.

Recombinant Human BCMA/TNFRSF17 Fc Chimera Protein, CF